These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25799919)

  • 1. 60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ögren SO
    Eur Neuropsychopharmacol; 2015 May; 25(5):591-8. PubMed ID: 25799919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ove Ögren S
    Eur Neuropsychopharmacol; 2015 May; 25(5):599-656. PubMed ID: 25836356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment.
    Millan MJ; Fone K; Steckler T; Horan WP
    Eur Neuropsychopharmacol; 2014 May; 24(5):645-92. PubMed ID: 24820238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic and epigenetic landscape for CNS drug discovery targeting cross-diagnostic behavioral domains.
    de Mooij-van Malsen AJ; Pjetri E; Kas MJ
    Eur J Pharmacol; 2015 Apr; 753():135-9. PubMed ID: 25107283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches in psychiatric drug development.
    van der Doef TF; Zaragoza Domingo S; Jacobs GE; Drevets WC; Marston HM; Nathan PJ; Tome MB; Tamminga CA; van Gerven JMA; Kas MJH
    Eur Neuropsychopharmacol; 2018 Sep; 28(9):983-993. PubMed ID: 30056086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress in NOS1AP in neurological and psychiatric diseases.
    Wang J; Jin L; Zhu Y; Zhou X; Yu R; Gao S
    Brain Res Bull; 2016 Jul; 125():99-105. PubMed ID: 27237129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches to the study of postmortem brain in psychiatric illness: old limitations and new challenges.
    McCullumsmith RE; Meador-Woodruff JH
    Biol Psychiatry; 2011 Jan; 69(2):127-33. PubMed ID: 21094488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
    Rudan I
    Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and psychiatric disorders: From aetiology to treatment.
    Luoni A; Riva MA
    Pharmacol Ther; 2016 Nov; 167():13-27. PubMed ID: 27452338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of CNS disorders.
    McGonigle P
    Biochem Pharmacol; 2014 Jan; 87(1):140-9. PubMed ID: 23811310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotherapy as an epigenetic 'drug': psychiatric therapeutics target symptoms linked to malfunctioning brain circuits with psychotherapy as well as with drugs.
    Stahl SM
    J Clin Pharm Ther; 2012 Jun; 37(3):249-53. PubMed ID: 22594604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European College of Neuropsychopharmacology (ECNP) - 23rd Congress.
    Finn DP
    IDrugs; 2010 Nov; 13(11):753-5. PubMed ID: 21046518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders.
    Kas MJ; Krishnan V; Gould TD; Collier DA; Olivier B; Lesch KP; Domenici E; Fuchs E; Gross C; Castrén E
    Eur Neuropsychopharmacol; 2011 Jul; 21(7):532-44. PubMed ID: 21237620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic rodent models of brain disorders: Perspectives on experimental approaches and therapeutic strategies.
    McGraw CM; Ward CS; Samaco RC
    Am J Med Genet C Semin Med Genet; 2017 Sep; 175(3):368-379. PubMed ID: 28910526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS Target Identification and Validation: Avoiding the Valley of Death or Naive Optimism?
    Hutson PH; Clark JA; Cross AJ
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():171-187. PubMed ID: 27575715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy.
    Millan MJ; Agid Y; Brüne M; Bullmore ET; Carter CS; Clayton NS; Connor R; Davis S; Deakin B; DeRubeis RJ; Dubois B; Geyer MA; Goodwin GM; Gorwood P; Jay TM; Joëls M; Mansuy IM; Meyer-Lindenberg A; Murphy D; Rolls E; Saletu B; Spedding M; Sweeney J; Whittington M; Young LJ
    Nat Rev Drug Discov; 2012 Feb; 11(2):141-68. PubMed ID: 22293568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities.
    Esposito G; Burgunder JM; Dunlop J; Gorwood P; Inamdar A; Pfister SM; Pochet R; van den Bent MJ; Van Hoylandt N; Weller M; Westphal M; Wick W; Nutt D
    Public Health Genomics; 2016; 19(3):170-7. PubMed ID: 27238144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in nutrition, genes and brain health.
    Dauncey MJ
    Proc Nutr Soc; 2012 Nov; 71(4):581-91. PubMed ID: 22716958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.